The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Brexit, Coronavirus, AstraZeneca

Sun, 13th Dec 2020 18:57

(Sharecast News) - Britain and the EU have taken a step forward towards striking a post-Brexit trade and security deal after Boris Johnson and Ursula von der Leyen agreed to "go the extra mile" and ordered the resumption of talks in Brussels. The prime minister played down expectations following the telephone conversation with the European commission president, telling the cabinet to prepare for a no-deal exit when the transition period ends in three weeks' time. But in Brussels, EU embassies were briefed by the commission that "progress has been made" and that "the next days will be important". - Guardian

Britain could be "back to normal" by summer as long as it avoids a third wave after Christmas, the British scientist behind a Covid vaccine has said. Professor Sarah Gilbert, the lead researcher on the Oxford vaccine, said "people's behaviour in the coming weeks is going to have a big impact" on when facemasks and social distancing requirements can be dropped. She said that a spike in coronavirus cases in January would disrupt vaccination programmes. - Sunday Times

Britain's biggest maker of pharmaceuticals has swooped on an American rival in a daring move on the eve of Brexit. Astra Zeneca, the FTSE 100 drug-maker playing a central role in the fight against Covid-19, has agreed to buy Alexion Pharmaceuticals for $39bn (£28.9bn). The cash-and-shares deal will cement the Anglo-Swedish giant's position in immunology and give it a dedicated rare disease business based in Boston, Massachusetts. - Sunday Times

Keith Williams is a man of many modes of transport. The corporate veteran spent 18 years at airline British Airways - the final five as chief executive and chairman - and will in the New Year publish his long-awaited review into the rail industry. Now he is the boss of Royal Mail - and drones are firmly on his radar. Williams wants to use the unmanned vehicles to fly letters to remote areas in the UK. 'If you take, say, the Scilly Isles - an expensive piece of water [to cross] - they might be ideally suited to a drone,' he says. - Mail on Sunday

More Leave voters than Remainers have swung from the Tories to Labour since the last election, according to a major polling project that suggests Keir Starmer, the Labour leader, has made some early progress in bridging the Brexit divide. A large 7,000-strong poll, designed to examine the political changes that have taken place since Labour's disastrous result, found that the party was showing signs of winning over some of those who backed the Tories last year. - Guardian

Giant American fashion and investment corporations are eyeing up bids for Topshop and its parent group Arcadia. [...] Around 30 to 40 potential buyers are believed to have shown initial interest and have received a limited information pack on the business from Arcadia's administrators, Deloitte. First-round bids are due in by the end of this week. - Mail on Sunday

A French satellite giant is muscling in on Britain's broadband market by targeting half a million people in the remotest parts of the nation. Eutelsat has launched Konnect, a satellite broadband service for homes that will not benefit from industry efforts to carpet Britain in gigabit speed connectivity. The service was rolled-out in the UK last week ahead of expanding across Europe and parts of Africa using the same satellite infrastructure. - Sunday Telegraph

Mike Ashley is racing to complete a deal to buy Debenhams this weekend, sources have told The Mail on Sunday. The sportswear mogul is in talks to buy the £500million web business - to help him crack the high-end cosmetics market - but the Debenhams store chain has been vastly slimmed down. 'There's very little time left to rescue the business,' said one City source. 'But without at least 30 or 40 of the 124Nightcap stores, this might not look very much like a rescue at all.' - Mail on Sunday

Dragons' Den entrepreneur Sarah Willingham is preparing to float a chain of city-centre bars with a team including celebrity chef Raymond Blanc, despite the malaise gripping leisure. Willingham, 46, has agreed a counterintuitive deal to buy London Cocktail Club through a stock market listing of her investment vehicle, Nightcap, on AIM in the coming weeks. She plans to raise £6m at a valuation of £14m. - Sunday Times



More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.